T4478 |
CID 16020046
|
834903-43-4
|
99.59%
|
|
CID 16020046 (C390-0219) is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.
|
T36520 |
COR659
|
544450-68-2
|
99.56%
|
|
COR659 is a GABAB positive allosteric modulator (PAM) . COR659 suppresses alcohol and chocolate self-administration in rats[1].
COR659 apparently exerts its effe...
|
T8571 |
ML-184
|
794572-10-4
|
99.53%
|
|
ML-184 (CID2440433) is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM.
|
T1796 |
Otenabant hydrochloride
|
686347-12-6
|
99.52%
|
|
Otenabant hydrochloride (Otenabant) (CP-945598) is a competitive, high affinity, selective antagonist of the CB1 receptor (Ki: 0.7 nM).
|
T67745 |
CB2R/FAAH modulator-2
|
2876918-68-0
|
99.52%
|
|
CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-2 acts as a CB2R agonist and FAAH inhibitor, the Ki value...
|
T6417 |
BML-190
|
2854-32-2
|
99.51%
|
|
BML-190 (Indomethacin morpholinylamide) is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over CB1 receptor.
|
T0851 |
Pregnenolone
|
145-13-1
|
99.5%
|
|
Pregnenolone (Arthenolone) is an endogenous steroid hormone synthesized from cholesterol, used in the treatment of Alzheimer's disease.
|
T1519 |
Rimonabant hydrochloride
|
158681-13-1
|
99.5%
|
|
Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity.
|
T12307 |
OMDM-6
|
616884-67-4
|
99.49%
|
|
OMDM-6 is a dual agonist of TRPV1(EC50 = 75 nM) and CB1 (Ki = 3.2 μM). OMDM-6 inhibits anandamide cellular uptake with a Ki of 7.0 μM.
|
T41231 |
GP 1a
|
511532-96-0
|
99.44%
|
|
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold m...
|
T30252 |
AZD1940
|
881413-29-2
|
99.43%
|
|
AZD1940 (UNII-0J0035E9FT) is a high affinity CB(1)/CB(2) receptor agonist of the cannabinoid with oral activity. Application in the study of orofacial pain.
|
T23097 |
O-1602
|
317321-41-8
|
99.4%
|
|
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of...
|
TP1901L1 |
Hemopressin (rat) acetate(568588-77-2 free base)
|
TP1901L1
|
99.37%
|
|
Hemopressin (rat) acetate is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. Hemopressin is orally acti...
|
T13289 |
EHP-101
|
1818428-24-8
|
99.22%
|
|
EHP-101 (VCE-004.8) is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. EHP-101 attenuates adipogenesis and prevents die...
|
T21380 |
Pravadoline
|
92623-83-1
|
99.20%
|
|
Pravadoline (WIN48098-6) is a cannabinoid receptor agonist. Pravadoline inhibited the PGs synthesis in mouse brain and displayed antinociceptive activity in rode...
|
T2264 |
AM281
|
202463-68-1
|
99.2%
|
|
AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.
|
T10694 |
CB1 inverse agonist 1
|
852315-00-5
|
99.12%
|
|
CB1 inverse agonist 1 (MRL-650) is an orally active and selective CB1 agonist. The IC50s for CB1 and CB2 are 7.5 nM and 4100 nM, respectively. CB1 inverse agonis...
|
T9114 |
β-Caryophyllene
|
87-44-5
|
99.11%
|
|
β-Caryophyllene ((-)-(E)-Caryophyllene) acts as an CB2 receptor agonist.
|
TN3575 |
(±)-Cannabichromene
|
20675-51-8
|
99.1%
|
|
(±)-Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyri...
|
T67747 |
CB2R/FAAH modulator-3
|
2876918-67-9
|
99.02%
|
|
CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-3 acts as a CB2R agonist and FAAH inhibitor, the Ki values are...
|